Status:
COMPLETED
TWK10 Improves Muscle Mass and Functional Performance in Frail Older Adults
Lead Sponsor:
National Taiwan Sport University
Collaborating Sponsors:
Synbio Tech Inc.
Conditions:
Frail Elderly Syndrome
Sarcopenia
Eligibility:
All Genders
65-90 years
Phase:
NA
Brief Summary
To explore the effect of "Lactobacillus plantarum TWK10 (hereinafter referred to as TWK10)" produced by synbiotech Biotechnology Co., Ltd. on alleviating and improving the aging and debilitating disea...
Eligibility Criteria
Inclusion
- The clinical frailty scale (Clinical Frailty Scale, CFS) assessed as frailty grade 1\~4.
Exclusion
- Diagnosed by the attending physician and confirmed that there is no stroke, hypertension patients and no exercise contraindications
- Can't sit to stand independently
- long-term antibiotics.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04893746
Start Date
July 1 2020
End Date
April 30 2021
Last Update
July 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan Sport University
Taoyuan District, Taiwan, 333